Jerome A Zack Selected Research

Jerome A Zack Research Topics

Disease

28	Infections 01/2021 - 02/2002
17	HIV Infections (HIV Infection) 10/2022 - 08/2002
16	Neoplasms (Cancer) 11/2021 - 08/2002
10	Acquired Immunodeficiency Syndrome (AIDS) 01/2020 - 03/2002
5	Disease Progression 01/2020 - 07/2013
4	Viremia 10/2022 - 02/2006
4	Virus Diseases (Viral Diseases) 01/2017 - 02/2006
4	Melanoma (Melanoma, Malignant) 05/2015 - 12/2011
2	Graft vs Host Disease (Graft-Versus-Host Disease) 08/2023 - 10/2019
2	Lymphoma (Lymphomas) 11/2021 - 01/2005
2	Shock 01/2020 - 01/2015
2	Latent Infection 01/2019 - 09/2017
1	Nervous System Diseases (Neurological Disorders) 01/2020
1	Leukemia 01/2020
1	Macular Degeneration (Age-Related Maculopathy) 10/2017
1	Retinal Degeneration 10/2017
1	Chronic Disease (Chronic Diseases) 01/2017
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 04/2016
1	Alzheimer Disease (Alzheimer's Disease) 09/2012
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 07/2010
1	Testicular Germ Cell Tumor 01/2009
1	Glioblastoma (Glioblastoma Multiforme) 01/2006
1	Kaposi Sarcoma (Kaposi's Sarcoma) 11/2005
1	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 11/2005
1	Primary Effusion Lymphoma 11/2005
1	Inflammation (Inflammations) 11/2005

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 08/2023 - 05/2004
5	Chimeric Antigen ReceptorsIBA 11/2021 - 01/2016
5	T-Cell Antigen Receptors (T-Cell Receptor)IBA 05/2015 - 12/2011
4	DNA (Deoxyribonucleic Acid)IBA 10/2019 - 02/2002
4	CytokinesIBA 06/2015 - 01/2003
4	Phorbol EstersIBA 01/2012 - 08/2002
4	prostratinIBA 01/2012 - 08/2002
3	VaccinesIBA 01/2017 - 10/2005
3	Antiviral Agents (Antivirals)IBA 01/2017 - 04/2009
3	Cocaine (Cocaine HCl)IBA 06/2015 - 03/2002
3	AntigensIBA 05/2015 - 10/2005
2	Interleukin-16 (Interleukin 16)IBA 01/2021 - 04/2009
2	BryostatinsIBA 01/2020 - 09/2012
2	bryostatin 1IBA 01/2020 - 08/2014
2	Interferon Type IIBA 01/2015 - 03/2005
2	AntibodiesIBA 01/2015 - 11/2005
2	CD4 Antigens (CD4 Antigen)IBA 09/2014 - 06/2004
2	Peptides (Polypeptides)IBA 05/2014 - 02/2002
2	Raltegravir Potassium FDA Link 01/2012 - 08/2011
2	Chemokine CXCL12IBA 04/2009 - 01/2003
2	RNA (Ribonucleic Acid)IBA 02/2006 - 01/2003
2	ChemokinesIBA 11/2005 - 03/2003
1	Initiator Codon (Start Codon)IBA 10/2019
1	Transcription Activator-Like Effector NucleasesIBA 01/2019
1	DystrophinIBA 04/2016
1	Single-Chain AntibodiesIBA 01/2016
1	InterferonsIBA 01/2015
1	Human Immunodeficiency Virus ProteinsIBA 01/2015
1	Neoplasm Antigens (Tumor Antigens)IBA 05/2013
1	NucleotidesIBA 04/2013
1	12-deoxyphorbolphenylacetateIBA 01/2012
1	Reverse Transcriptase InhibitorsIBA 01/2012
1	efavirenz (Sustiva)FDA Link 01/2012
1	Anti-Retroviral Agents (Antiretroviral Agents)IBA 01/2012
1	HLA-A*02:01 antigenIBA 12/2011
1	Integrase InhibitorsIBA 08/2011
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 07/2010
1	Cytidine DeaminaseIBA 07/2010
1	plerixafor FDA Link 04/2009
1	LigandsIBA 04/2009
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2009
1	Cyclin-Dependent Kinase Inhibitor p27IBA 11/2008
1	enhanced green fluorescent proteinIBA 07/2007
1	LuciferasesIBA 07/2007
1	Interleukin-7 (Interleukin 7)IBA 03/2007
1	Interleukin-15 (Interleukin 15)IBA 03/2007
1	Viral RNAIBA 02/2006
1	TensinsIBA 01/2006
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2006
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 11/2005
1	Epinephrine (Adrenaline)FDA LinkGeneric 11/2005
1	Cyclic AMP (AMP, Cyclic)IBA 11/2005
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 11/2005
1	Neurotransmitter Agents (Neurotransmitter)IBA 11/2005
1	Adrenergic Agents (Adrenergic Drugs)IBA 11/2005
1	Chemokine CXCL13IBA 11/2005
1	CatecholaminesIBA 11/2005
1	Thymidine KinaseIBA 10/2005
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 03/2005
1	NF-kappa B (NF-kB)IBA 03/2005
1	Proteasome InhibitorsIBA 01/2005
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2005
1	Bortezomib (Velcade)FDA Link 01/2005
1	Fas Ligand Protein (Fas Ligand)IBA 06/2004
1	Transcription Factors (Transcription Factor)IBA 10/2003
1	Immunotoxins (Immunotoxin)IBA 09/2003

Therapy/Procedure

15	Therapeutics 10/2022 - 02/2002
8	Immunotherapy 11/2021 - 12/2011
5	Highly Active Antiretroviral Therapy (HAART) 01/2021 - 08/2002
4	Art Therapy 12/2020 - 01/2015
2	Transplantation 10/2017 - 01/2009
1	Hematopoietic Stem Cell Transplantation 11/2021
1	Ligation 09/2014
1	Cell- and Tissue-Based Therapy (Cell Therapy) 05/2014